Home   >  
Microbiology/Virology
  >  
SARS CoV
  >   Ensitrelvir fumarate
Ensitrelvir fumarate Chemical Structure

Ensitrelvir fumarate

Data Sheet For research use only. Not for human use.
Cat. No. :BCP46193CAS No. :2757470-18-9Purity:98%
Size Price Stock Quotation Inquiry
10.00 mg Get quote In-stock Quotation Inquiry
25.00 mg Get quote In-stock Quotation Inquiry
50.00 mg Get quote In-stock Quotation Inquiry
 Tel: 0086-13026320035   or   orders@biochempartner.com
Real-Time Inquiry ×

* Required Fields.

Please complete the form below and you will get the price list in 1 minute.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

Inquiry Online ×

* Required Fields.

Please complete the form below and we will contact you shortly.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

Bulk Inquiry ×

* Required Fields.

Please complete the form below and we will contact you shortly.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

  • Chemical Properties&Biological Activity
CAS No. 2757470-18-9 Cat. No. BCP46193
Name Ensitrelvir fumarate
Synonyms S-217622 fumarate; S 217622 fumarate; S217622 fumarate;
SMILES CN1C=C2C=C(C(=CC2=N1)Cl)NC3=NC(=O)N(C(=O)N3CC4=CC(=C(C=C4F)F)F)CC5=NN(C=N5)C.C(=CC(=O)O)C(=O)O
Chemical Name
Formula C26H21ClF3N9O6 M. Wt 647.96
Purity 98% Storage Store at 4-8°C
Description Ensitrelvir, also known as S-217622, is an antiviral drug developed by Shionogi in partnership with Hokkaido University, which acts as an orally active 3C-like protease inhibitor for the treatment of COVID-19 infection. It is taken by mouth, and has been successfully tested against the recently emerged Omicron variant. It is the first orally active non-covalent, non-peptidic, SARS-CoV-2 3CL protease inhibitor (IC50=13 nM). It became the first Japanese domestic pill to treat COVID-19, third to be regulatorally approved in Japan; in February 2022.
  • Quality Control&Technical Support
In the process of purchasing and using Biochempartner products, you can consult us if you have any problems: orders@biochempartner.com. We will try our best to solve all your doubts.

Recommend Products

More >

Tags:Ensitrelvir fumarate supplier,Ensitrelvir fumarate purchase,Ensitrelvir fumarate manufacturer,Ensitrelvir fumarate distributor,Ensitrelvir fumarate cost,Ensitrelvir fumarate buy,Ensitrelvir fumarate for sale

0086-13720134139